Generics Eric Ng received his degree at National University of Singapore. In his career he has worked for such companies as AstraZeneca before moving to Sanofi-Aventis China until his rise in rank to President Director of Sanofi in Indonesia. Today he talks about the stiff competition in Indonesia in the generics…
Juan Diego Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you say that Siplas has been able to take advantage of that potential? And if so, how? Siplas has been growing…
Cedegim Colombia The operations and sales managers of Cegedim Colombia discuss the impact of healthcare reform on the Colombian pharma market, partnering opportunities in the country, and the outlook for CRM in 2013 and beyond. Can you briefly summarize Cegedim Colombia’s scope of activities and…
Espíndola International Consultants An expert in trade and regulatory issues relating to the pharmaceutical industry in Colombia, the senior partner of Espíndola International Consultants offers his opinions on the steps taken by the Colombian authorities to improve quality and reduce corruption in the sector, as well as discussing the steps to maintain cost containment…
Cegedim Belgium October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the skills you’ve acquired in your career at Therabel and B Braun – both pharmaceutical and medical devices companies, apply to Cegedim? What were some of main…
China Chen Qiyu, chairman of Fosun Pharma, discusses how the company is helping China achieve its ‘Healthy China 2020’ goals as well as its unique business model and company culture. Fosun Pharma is an integrated pharmaceutical company with interests all along the value chain, from API to finished products, distribution, medical…
Cegedim Czech Republic Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company grow significantly through a series of mergers. What has been the historical development of the Czech affiliate? Tomáš Nádvorník: Cegedim was established in the Czech Republic in…
Aspen The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and manufacturing infrastructure”. What was the original strategy behind getting the best from the Mexican market – specifically with the acquisition of the Latin America business from India-based Strides Arcolab…
Cegedim Romania To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have been your main milestones and achievements since you have joined? Having been with a local and regional company at first, it has been quite…
Cegedim Poland Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the market to the international readers of Pharmaceutical Executive? On the one hand the pressures and incentives influencing the main stakeholders are the same as elsewhere. But…
See our Cookie Privacy Policy Here